Quantum-Si (QSI) Expected to Announce Earnings on Thursday

Quantum-Si (NASDAQ:QSI) is anticipated to post its Q1 2026 results after the market closes on Thursday, May 7th. Analysts expect Quantum-Si to post earnings of ($0.12) per share and revenue of $0.2990 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Thursday, May 7, 2026 at 4:30 PM ET.

Quantum-Si (NASDAQ:QSI) last announced its earnings results on Tuesday, March 3rd. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.06. Quantum-Si had a negative return on equity of 43.90% and a negative net margin of 4,160.06%.The business had revenue of $0.45 million during the quarter, compared to the consensus estimate of $0.76 million. On average, analysts expect Quantum-Si to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Quantum-Si Stock Up 4.5%

Shares of NASDAQ QSI traded up $0.04 during mid-day trading on Wednesday, hitting $1.01. 1,803,667 shares of the company traded hands, compared to its average volume of 4,457,358. Quantum-Si has a 1 year low of $0.69 and a 1 year high of $3.10. The stock has a market capitalization of $217.45 million, a price-to-earnings ratio of -1.95 and a beta of 3.15. The business has a 50 day moving average of $0.89 and a two-hundred day moving average of $1.22.

Insiders Place Their Bets

In related news, CEO Jeffrey Alan Hawkins sold 83,712 shares of the stock in a transaction dated Monday, April 20th. The stock was sold at an average price of $1.01, for a total value of $84,549.12. Following the completion of the sale, the chief executive officer directly owned 3,776,135 shares of the company’s stock, valued at approximately $3,813,896.35. This represents a 2.17% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Charles R. Kummeth acquired 500,000 shares of Quantum-Si stock in a transaction that occurred on Thursday, March 5th. The stock was acquired at an average cost of $0.92 per share, with a total value of $460,000.00. Following the completion of the purchase, the director owned 855,000 shares in the company, valued at approximately $786,600. This represents a 140.85% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders sold a total of 212,904 shares of company stock valued at $205,021 in the last 90 days. Insiders own 22.04% of the company’s stock.

Institutional Investors Weigh In On Quantum-Si

Several hedge funds have recently bought and sold shares of QSI. Invesco Ltd. lifted its stake in Quantum-Si by 177.7% in the 1st quarter. Invesco Ltd. now owns 103,657 shares of the company’s stock worth $124,000 after acquiring an additional 66,336 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Quantum-Si by 23.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 70,552 shares of the company’s stock worth $85,000 after purchasing an additional 13,546 shares during the last quarter. Millennium Management LLC acquired a new position in Quantum-Si in the 1st quarter worth about $4,721,000. JPMorgan Chase & Co. increased its position in Quantum-Si by 15.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 66,656 shares of the company’s stock worth $131,000 after purchasing an additional 9,005 shares during the last quarter. Finally, Rhumbline Advisers increased its position in Quantum-Si by 36.0% in the 2nd quarter. Rhumbline Advisers now owns 203,967 shares of the company’s stock worth $400,000 after purchasing an additional 53,994 shares during the last quarter. 39.90% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on QSI. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Quantum-Si in a report on Friday, March 27th. Canaccord Genuity Group reduced their target price on Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday, March 4th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $3.25.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.